Similar articles

• Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

  Hundt S, Haug U, Brenner H. Hundt S, et al. Ann Intern Med. 2009 Feb 3;150(3):162-9. doi: 10.7326/0003-4819-150-3-200902030-00005. Ann Intern Med. 2009. PMID: 19189905
• Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.

  Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, Han DS. Park DI, et al. Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25. Am J Gastroenterol. 2010. PMID: 20502450
• Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

  van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. van Rossum LG, et al. Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25. Gastroenterology. 2008. PMID: 18482589 Clinical Trial.
• New fecal occult blood tests may improve adherence and mortality rates.

  Kumaravel V, Hayden SP, Hall GS, Burke CA. Kumaravel V, et al. Cleve Clin J Med. 2011 Aug;78(8):515-20. doi: 10.3949/ccjm.78a.11024. Cleve Clin J Med. 2011. PMID: 21807923 Review.
• Fecal occult blood test in colorectal cancer screening.

  Li JN, Yuan SY. Li JN, et al. J Dig Dis. 2019 Feb;20(2):62-64. doi: 10.1111/1751-2980.12712. Epub 2019 Mar 5. J Dig Dis. 2019. PMID: 30714325 Review.